ramorelix

restricts tumor growth induced by dimethylbenz(a)anthracene; amino acid sequence given in first source

Also Known As:

Ac-Nal(2)-4-Cl-Phe-Trp-Ser-Tyr-Ser(Rha)-Leu-Arg-Pro-AzGly-NH2; Hoe 013; Hoe-013; L-Proline, 1-(N2-(N-(N-(N-(N-(N-(N-(N-acetyl-3-(1-naphthalenyl)-D-alanyl)-4-chloro-D-phenylalanyl)-D-tryptophyl)-L-seryl)-L-tyrosyl)-O-(6-deoxy-alpha-L-mannopyranosyl)-D-seryl)-L-leucyl)-L-arginyl)-, 2-(aminocarbonyl)hydrazide

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - ramorelix: 1

Related Diseases

1.	Carcinoma (Carcinomatosis) 01/01/1993 - "Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations."

Related Drugs and Biologics

1.	Gonadotropin-Releasing Hormone (GnRH)
2.	Buserelin (Suprefact)
3.	anthracene